Clinical Trials Logo

Filter by:
NCT ID: NCT02475356 Completed - Clinical trials for Menorrhagia, Dysmenorrhea

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

J-MIRAI
Start date: August 4, 2015
Phase:
Study type: Observational

The primary objective in this study is collecting post-marketing information on the safety. Thus, it includes information under the routine clinical practice on adverse events (AEs) and adverse drug reactions (ADRs) including expulsion and abnormal bleeding that occur within the first 12 months Mirena insertion. The secondary objective(s) in this study is/are collecting information on Mirena effectiveness, such as periodic blood loss and Quality of life (QOL), use of analgesic and dysmenorrhea pain as far as these are recorded under routine clinical practice.

NCT ID: NCT02473393 Completed - Bacterial Enteritis Clinical Trials

A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

Start date: August 20, 2015
Phase: Phase 2
Study type: Interventional

To assess safety, efficacy and pharmacokinetics of multiple dosesin patients with Bacterial Enteritis caused by Clostridium difficile infection(CDI) or Enteric infection.

NCT ID: NCT02471586 Completed - Clinical trials for Coronary Artery Disease

OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation

ILUMIEN III
Start date: May 2015
Phase: N/A
Study type: Interventional

The objective of this clinical investigation is to demonstrate the safety and efficacy of an OCT guided strategy for stent implantation

NCT ID: NCT02471144 Completed - Clinical trials for Chronic Severe Plaque-type Psoriasis

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Start date: September 29, 2015
Phase: Phase 3
Study type: Interventional

This was a multicenter, randomized, double-blind, placebo- and active-controlled (etanercept in single blinded arm) study in pediatric subjects aged 6 years to less than 18 years with severe chronic plaque psoriasis. Approximately 160 subjects aged 6 years to <18 years were enrolled, of which at least 30 were 6 years to <12 years old. Subjects were enrolled at approximately 70 study sites worldwide.

NCT ID: NCT02469688 Completed - Cedar Pollinosis Clinical Trials

A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

Start date: June 18, 2015
Phase: Phase 1
Study type: Interventional

Examine safety and immunological response for ASP4070 when vaccinated in patients with pollen allergy

NCT ID: NCT02468674 Completed - Sarcopenia Clinical Trials

A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study

Start date: July 22, 2015
Phase: Phase 2
Study type: Interventional

This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study and the main objective was to determine the long-term durability of bimagrumab (BYM338) effect after a 6-month treatment period.

NCT ID: NCT02468466 Completed - Suicide Clinical Trials

A Community-based Depression Screening Intervention for Middle-aged Suicide

Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of a community-based depression-screening program for suicide prevention among middle-aged adults, the investigators conducted a quasi-experimental intervention study, using a parallel cluster design with communities at municipal level as the unit of allocation and individuals as the unit of analysis.

NCT ID: NCT02468232 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction (HF-rEF)

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

PARALLEL-HF
Start date: June 15, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study was to assess the effect of LCZ696 at a target dose of 200 mg b.i.d. compared to enalapril 10 mg b.i.d., in addition to the background heart failure (HF) treatment, on delaying time to first occurrence of either cardiovascular (CV) death or HF hospitalization events in Japanese patients with stable chronic heart failure (CHF), New York Heart Association (NYHA) classes II-IV and reduced ejection fraction (left ventricular ejection fraction (LVEF) ≤ 35%).

NCT ID: NCT02468193 Completed - Cushing's Syndrome Clinical Trials

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Start date: September 24, 2015
Phase: Phase 2
Study type: Interventional

The study aim was to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.

NCT ID: NCT02466412 Completed - Smoking Clinical Trials

Nicotine Pharmacokinetic Profile of the CHTP 1.1 M

Start date: May 2015
Phase: N/A
Study type: Interventional

The primary objective of this clinical study is to evaluate the pharmacokinetic (PK) profile of nicotine (rate and amount of nicotine absorbed) after single use of the Carbon Heated Tobacco Product 1.1 Menthol (CHTP 1.1 M), a potential Modified Risk Tobacco Product, compared to menthol cigarettes (mCC) in healthy smokers.